# DataMeds AI, Inc. (WGRX) — delisting/voluntary [announced]
Source: sec.gov · situation sit_ba12be7cb4351b4cbd3e · public 9008703818526235756 · retrieved 2026-08-19T11:34:37.137Z

## Overview
DataMeds AI, Inc. is an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx combined with blockchain-enabled smart contracts platform PharmacyChain to provide integrated solutions for compliant healthcare delivery and health data monetization.

DataMeds AI, Inc. (NASDAQ: MEDS) disclosed a pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings, and HealthBridge Associates to consolidate patent-protected blockchain, biometrics, and pharmaceutical-adjunct product intellectual properties. The transaction is intended to support the development and launch of the "Health Lives Here" consumer app in partnership with NFL Alumni Health (NFLAH), targeting patients in rural communities through local independent pharmacies. The company also noted that it entered into an agreement to expand the Datavault AI PharmacyChain license to all commercial healthcare, acquire QOLPOM patent portfolios for biometric confirmation of drug consumption and delivery via drones, and acquire a controlling interest in Tollo Health (collectively the "Datavault Transaction"). The filing indicates the transaction terms were updated for tax optimization in Q3 2026, with closing expected as a remaining second-half 2026 milestone.

## Terms
- Counterparty: Datavault AI, EOS Technology Holdings, Scilex Holdings, HealthBridge Associates

## Key dates
- Announced 2026-08-18

## Timeline
- 2026-08-18 · 8-K (0001493152-26-038891): 8-K - DataMeds AI, Inc. — *DataMeds AI, Inc. is an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence platform EinsteinRx combined with blockchain-enabled smart contracts platform PharmacyChain to provide integrated solutions for compliant healthcare delivery and health data monetization.* DataMeds AI, Inc. (NASDAQ: MEDS) disclosed a pending transaction with Datavault AI, EOS Technology Holdings, Scilex Holdings, and HealthBridge Associates to consolidate patent-protected blockchain, biometrics, and pharmaceutical-adjunct product intellectual properties. The transaction is intended to support the development and launch of the "Health Lives Here" consumer app in partnership with NFL Alumni Health (NFLAH), targeting patients in rural communities through local independent pharmacies. The company also noted that it entered into an agreement to expand the Datavault AI PharmacyChain license to all commercial healthcare, acquire QOLPOM patent portfolios for biometric confirmation of drug consumption and delivery via drones, and acquire a controlling interest in Tollo Health (collectively the "Datavault Transaction"). The filing indicates the transaction terms were updated for tax optimization in Q3 2026, with closing expected as a remaining second-half 2026 milestone.
  https://www.sec.gov/Archives/edgar/data/2030763/0001493152-26-038891.txt

## Citations
- 0001493152-26-038891 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226038891